Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen

Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen

US Patent 11851483 · Granted Dec 26, 2023

Estimated economic value: $386,756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and meth2025
Calibration of circuitry parameters for current sensing2025
System and method of accelerating polymer fiber stabilization via irradiation tr2025
Methods and apparatus for random access in multi-carrier communication systems2025
Methods and apparatus for contingency communications2025
Methods and apparatus for multi-carrier communications with variable channel ban2025
DKK1 antibodies and methods of use2025
Methods and apparatus for power efficient broadcasting and communication systems2025
Hydraulic control system for boom floating of excavator and control method there2025
Crystal form of pyrazolyl-amino-pyrimidinyl derivative, and preparation method t2024
TYK2 inhibitors and compositions and methods thereof2024
Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and meth2024